Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Tyrosine-protein kinase ITK/TSK inhibitors discovered at Pfizer

July 14, 2021

EscharEx debridement agent demonstrates efficiency, safety in chronic wound study

July 13, 2021

FDA clears initiation of phase II trial of pyrilutamide in androgenetic alopecia

July 12, 2021

Kymera reports interim phase I SAD data on IRAK-4 degrader KT-474

June 28, 2021

Follicum discontinues development of FOL-005 for alopecia

June 25, 2021

Kaken begins Japanese phase I study of sofpironium bromide gel in primary palmoplantar hyperhidrosis

June 25, 2021

Titan reports in vivo data on TP-2021 implant in model of chronic pruritus

June 25, 2021

Nankai University identifies new compounds for skin injury

June 16, 2021

LEO Pharma initiates phase IIa study of LEO-152020 in cholinergic urticaria

June 16, 2021

Topline phase Ib data reported on RPT-193 in atopic dermatitis

June 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026